184 related articles for article (PubMed ID: 22847180)
1. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
Kumari R; Li H; Haudenschild DR; Fierro F; Carlson CS; Overn P; Gupta L; Gupta K; Nolta J; Yik JH; Di Cesare PE
Carcinogenesis; 2012 Nov; 33(11):2076-83. PubMed ID: 22847180
[TBL] [Abstract][Full Text] [Related]
2. Functional identification of LRF as an oncogene that bypasses RASV12-induced senescence via upregulation of CYCLIN E.
Vredeveld LC; Rowland BD; Douma S; Bernards R; Peeper DS
Carcinogenesis; 2010 Feb; 31(2):201-7. PubMed ID: 19942610
[TBL] [Abstract][Full Text] [Related]
3. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
[TBL] [Abstract][Full Text] [Related]
4. miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism.
Tang XY; Zheng W; Ding M; Guo KJ; Yuan F; Feng H; Deng B; Sun W; Hou Y; Gao L
Drug Des Devel Ther; 2016; 10():571-83. PubMed ID: 26966351
[TBL] [Abstract][Full Text] [Related]
5. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
Ravizza R; Gariboldi MB; Molteni R; Monti E
Oncol Rep; 2008 Sep; 20(3):625-30. PubMed ID: 18695915
[TBL] [Abstract][Full Text] [Related]
6. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.
Vigneron A; Roninson IB; Gamelin E; Coqueret O
Cancer Res; 2005 Oct; 65(19):8927-35. PubMed ID: 16204065
[TBL] [Abstract][Full Text] [Related]
7. Alendronate inhibits growth of high-grade chondrosarcoma cells.
Susa M; Morii T; Yabe H; Horiuchi K; Toyama Y; Weissbach L; Hornicek FJ; Morioka H
Anticancer Res; 2009 Jun; 29(6):1879-88. PubMed ID: 19528443
[TBL] [Abstract][Full Text] [Related]
8. Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion.
Tan ML; Choong PF; Dass CR
Biochem Biophys Res Commun; 2010 Aug; 398(4):613-8. PubMed ID: 20501323
[TBL] [Abstract][Full Text] [Related]
9. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
10. Relationship of p21 (waf1/cip1) and differentiation in chondrosarcoma cells.
Hiraoka K; Zenmyo M; Komiya S; Kawabata R; Yokouchi M; Suzuki R; Hamada T; Kato S; Nagata K
Virchows Arch; 2002 Mar; 440(3):285-90. PubMed ID: 11889599
[TBL] [Abstract][Full Text] [Related]
11. YAP is a candidate oncogene for esophageal squamous cell carcinoma.
Muramatsu T; Imoto I; Matsui T; Kozaki K; Haruki S; Sudol M; Shimada Y; Tsuda H; Kawano T; Inazawa J
Carcinogenesis; 2011 Mar; 32(3):389-98. PubMed ID: 21112960
[TBL] [Abstract][Full Text] [Related]
12. Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells.
van Oosterwijk JG; van Ruler MA; Briaire-de Bruijn IH; Herpers B; Gelderblom H; van de Water B; Bovée JV
Br J Cancer; 2013 Sep; 109(5):1214-22. PubMed ID: 23922104
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
14. Effects of ethanol on the anticancer function of doxorubicin in JJ012 cells.
Huang H; Li Y; Wu M; Luo J; Nie J; Hou B; He Q; Diao Y; Qi L; Zhao Y; Liu Y; Yang D; Zhou L
Future Oncol; 2018 Jun; 14(13):1285-1297. PubMed ID: 29774752
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib induces growth inhibition and apoptosis of human chondrosarcoma cells by blocking the RAF/ERK/MEK pathway.
Lu X; Tang X; Guo W; Ren T; Zhao H
J Surg Oncol; 2010 Dec; 102(7):821-6. PubMed ID: 20812347
[TBL] [Abstract][Full Text] [Related]
16. p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis.
de Belle I; Huang RP; Fan Y; Liu C; Mercola D; Adamson ED
Oncogene; 1999 Jun; 18(24):3633-42. PubMed ID: 10380885
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying the pro-survival pathway of p53 in suppressing mitotic death induced by adriamycin.
Lin YC; Wang FF
Cell Signal; 2008 Jan; 20(1):258-67. PubMed ID: 18006273
[TBL] [Abstract][Full Text] [Related]
18. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
Xu X; Tang X; Guo W; Yang K; Ren T
Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic significance of p53, HER-2/neu, Ki-67 and VEGF expression in chondrosarcomas].
Stepanova EV; Kharatishvili TK; Lichinitser MR; Baryshnikov AIu; Solov'ev IuN; Trapeznikov NN
Arkh Patol; 2002; 64(6):9-12. PubMed ID: 12534219
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]